On the relationship between innate and adaptive immunity in psoriasis

Bibliography:
1. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimar sson H. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004; 135(1): 1-8
2. Kastelan M, Massari LP, Pasic A, Gruber F. New trends in the immunopathogenesis of psoriasis. Acta Dermatovenerol Croat 2004; 12(1): 26-29
3. Ortonne JP Redefining clinical response in psoriasis: targeting the pathological basis of disease. J Drugs Dermatol 2004; 3(1): 13-20
4. Perlamutrov YN, Solov'ev AM. Psoriasis and modern methods of treatment. Therapist 2004; (5): 38-43
5. Lench N, lies MM, Mackay I, et al. Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatability complex haplotype for psoriasis in a Caucasian population. J Invest Dermatol 2005; 124 (3): 545-552
6. Rie MA, Goedkoop AY, Bos JD. Overview of psoriasis. Dermatol Ther2004; 17 (5): 341-349
7. Korotkij NG, Udzhuhu VY, Dvornikova TV. Modern approaches to the treatment of erythrodermic psoriasis. Ros. zhurn. leather, and Venus, diseases. 2001; (1): 7-11
8. Mukhtar R, Choi J, Коо JY Quality-of-life issues in psoriasis. Dermatol Clin 2004; 22 (4): 389-395
9. Marinina GN, Marinin VS. Treatment of psoriasis. 4th ed., rev. Kharkov: Spectrum, 2000. 104 p.
10. Belie D, Ristic-Nikolic S, Damjan S, et al. Heredity of psoriasis. Med Pregl. 2004; 57 (3-4): 171-174
11. Sagoo GS, Cork MJ, Patel R, Tazi-Ahnini R. Genome-wide studies of psoriasis susceptibility loci. J Dermatol Sci 2004; 35(3): 171179
12. Gupta R, Debbaneh MG, Liao W. Genetic Epidemiology of Psoriasis. Curr Dermatol Rep 2014; 3 (1): 61-78
13. Vasilca V, Vasilca A, Munteanu D, et al. HLA-B57 is significantly associated with psoriasis in Northeast Romania. Roum Arch Microbiol Immunol 2002; 61 (4): 259-265
14. Bahcetepe N, Kutlubay Z, Yilmaz E, Tuzun Y, Eren B. The role of HLA antigens in the aetiology of psoriasis. Med Glas (Zenica) 2013, 10 (2): 339-342
15. Ammar M, Souissi-Bouchlaka C, Gati A, et al. Psoriasis: physiopathology and immunogenetics. Pathol Biol (Paris) 2014; 62(1): 10-23
16. Valdimarsson H. The genetic basis of psoriasis. Clin Dermatol 2007; 25 (6): 563-567. 17. Elder JT, Henseler T, Christophers E. The genetic of psoriasis. Arch Dermatol 1994; 130: 216-224
18. Tomfohrde J, Silverman A, Barnes R. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994; 264: 1141-1145
19. Matthews D, PowlesA. V, Fry L. Conformation of genetic heterogeneity in familial psoriasis. J Invest Dermatol 1995; 105 (3): 457-461
20. Mordovtsev VN, Sukolin Gl, Sergeev AS. Epidemiology and genetics of psoriasis. In: Symposium on psoriasis dermatovenerologists socialist countries, 3rd: tez.dokl. Moscow, 1987; 89 p.
21. Vasileysky SS. The relationship of immunological and non-immune factors, the pathogenesis of psoriasis. Vestnik of Dermatology and Venereology 1990 (9): 26-29
22. Prinz JC. The role of T cells in psoriasis. Eur Acad Dermatol Venereol 2003; 17 (3): 257270
23. Prinz JC. Which T cells cause psoriasis? Clin Exp Dermatol 1999; 24 (4): 291-295
24. Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin 2015; 33 (1): 13-23
25. Coimbra S, FigueiredoA, Castro E, et al.The roles of cells and cytokines in the pathogenesis of psoriasis. Int J Dermatol 2012; 51 (4): 389-395
26. Alshenawy HA, Hasby EA. Immunophenotyping of dendritic cells in lesional, perilesional and distant skin of chronic plaque psoriasis. Cell Immunol 2011; 269 (2): 115-119
27. Mabrijan L. Adhesion molecules in keratinocytes. Clin Dermatol 2011; 29 (4): 427-431
28. Onuma S. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 1994; 21 (4): 223-232
29. Cabrijan L, Batinac T, Lenkovic M, Gruber F. The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1. Med Hypotheses 2009; 72 (3): 327-329
30. Christophers E, Metzler G, R4cken M. Bimodal immune activation in psoriasis. Br J Dermatol. 2014, 170 (1): 59-65
31. Shegay MM, Keshileva ZB, Akyshbaeva G. A The role of certain cytokines in the development of psoriasis. Vestnik of Dermatology and Venereology 1998; (5): 7-12
32. Varricchi G, Granata F, Loffredo S, Genovese A, Marone G. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol 2015; 73 (1): 144-153
33. Mitsui A, Tada Y, Shibata S, et al. Deficiency of both L-selectin and ICAM-1 exacerbates imiquimod-induced psoriasislike skin inflammation through increased infiltration of antigen presenting cells. Clin Immunol 2015; 157 (1): 43-55
34. Li W, Man XY, Chen JQ, Zhou J, Cai SQ. Zheng MTargeting VEGF/VEGFR in the treatment of psoriasis. Discov Med2014, 18 (98): 97-104
35. Edmondson SR, Thumiger SP, Werther GA, Wraight CJ. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 2003; 24 (6): 737-764
36. Ramirez-Bosca A, Martinez-Ojeda L, Valcuende-Cavero F, Castells-RodellasA. A study of local immunity in psoriasis. BrJ Dermatol 1988; 119 (5): 587-595
37. Ivanova IP, Mareeva ТЕ. Violations of lipid peroxidation, activity of lysosomal hydrolases and their correction in patients with psoriasis. Vestnik of Dermatology and Venereology 1987; (4): 26-31
38. Shilov VN, Sergienko VI. New approaches to the study of the pathogenesis and treatment of psoriasis. Vestnik of Dermatology and Venereology 1998; (3): 49-52
39. Kapuscinska R, Wysocka J, Zelazowska В, Niczyporuk W. Evaluation of neutrophils adhesive molecules CD11b/CD18 in course of photochemotherapy (PUVA) psoriasis vulgaris. Pol Merkuriusz Lek. 2004; 16 (96): 547-550
40. BakulevAL, Whistlers AA, Kravchenya SS. Some of the clinical and immunological features of endotoxemia in psoriasis
41. Bakulev AL, Kravchenya SS. Psoriasis of the scalp: new opportunities topical therapy. Journal of Dermatology and Venereology 2013; (2): 73-78.